共有 50 笔近期内部人交易记录记录，涉及 Gossamer Bio, Inc. (GOSS), 包括 34 笔买入 和 12 笔卖出. 内部人买入总额为 $11.99M 内部人卖出总额为 $3.09M.
近期活跃的重要内部人包括 Hasnain Faheem, Christian Waage, Giraudo Bryan. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — GOSS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-19 |
Hasnain Faheem |
President & CEO |
股份退回 |
47,000 |
$12.10 |
$568.7K |
- |
| 2026-03-19 |
Christian Waage |
EVP, Tech Ops and Admin |
股份退回 |
70,000 |
$1.36 |
$95.2K |
- |
| 2026-03-19 |
Giraudo Bryan |
COO/cfo |
股份退回 |
211,500 |
$2.16 |
$456.84K |
- |
| 2026-03-19 |
Peterson Caryn |
EVP, Regulatory Affairs |
股份退回 |
125,000 |
$0.84 |
$104.75K |
- |
| 2026-03-19 |
Aranda Richard |
Chief Medical Officer |
股份退回 |
157,500 |
$1.21 |
$190.58K |
- |
| 2026-03-19 |
Smith Robert Paul Jr |
Chief Commercial Officer |
股份退回 |
562,500 |
$2.88 |
$1.62M |
- |
| 2026-01-02 |
Hasnain Faheem |
President & CEO |
限制性股票授予 (RSU) |
280,000 |
- |
- |
837,793 |
| 2026-01-02 |
Giraudo Bryan |
COO/cfo |
限制性股票授予 (RSU) |
115,750 |
- |
- |
389,737 |
| 2026-01-02 |
Aranda Richard |
Chief Medical Officer |
限制性股票授予 (RSU) |
93,750 |
- |
- |
463,106 |
| 2026-01-02 |
Smith Robert Paul Jr |
Chief Commercial Officer |
限制性股票授予 (RSU) |
93,750 |
- |
- |
260,898 |
| 2025-06-25 |
Cox Russell J. |
Director |
限制性股票授予 (RSU) |
115,000 |
$1.36 |
$156.4K |
115,000 |
| 2025-06-25 |
Daniel Thomas O |
Director |
限制性股票授予 (RSU) |
115,000 |
$1.36 |
$156.4K |
115,000 |
| 2025-06-25 |
Quisel John D |
Director |
限制性股票授予 (RSU) |
115,000 |
$1.36 |
$156.4K |
115,000 |
| 2025-06-25 |
Milligan Sandra |
Director |
限制性股票授予 (RSU) |
115,000 |
$1.36 |
$156.4K |
115,000 |
| 2025-06-25 |
Drynan Skye |
Director |
限制性股票授予 (RSU) |
115,000 |
$1.36 |
$156.4K |
115,000 |
| 2025-06-25 |
Nathan Steven D |
Director |
限制性股票授予 (RSU) |
115,000 |
$1.36 |
$156.4K |
115,000 |
| 2025-03-04 |
Hasnain Faheem |
President & CEO |
限制性股票授予 (RSU) |
1,540,000 |
$1.13 |
$1.74M |
1,540,000 |
| 2025-03-04 |
Christian Waage |
EVP, Tech Ops and Admin |
限制性股票授予 (RSU) |
440,000 |
$1.13 |
$497.2K |
440,000 |
| 2025-03-04 |
Giraudo Bryan |
COO/cfo |
限制性股票授予 (RSU) |
638,000 |
$1.13 |
$720.94K |
638,000 |
| 2025-03-04 |
Peterson Caryn |
EVP, Regulatory Affairs |
限制性股票授予 (RSU) |
440,000 |
$1.13 |
$497.2K |
440,000 |
| 2025-03-04 |
Aranda Richard |
Chief Medical Officer |
限制性股票授予 (RSU) |
572,000 |
$1.13 |
$646.36K |
572,000 |
| 2025-03-04 |
Smith Robert Paul Jr |
Chief Commercial Officer |
限制性股票授予 (RSU) |
572,000 |
$1.13 |
$646.36K |
572,000 |
| 2024-06-24 |
Aranda Richard |
Chief Medical Officer |
知情卖出 |
1,908 |
$0.66 |
$1.26K |
196,891 |
| 2024-06-21 |
Hasnain Faheem |
President & CEO |
知情买入 |
372,000 |
$0.67 |
$250.28K |
5,408,073 |
| 2024-06-18 |
Giraudo Bryan |
COO/cfo |
知情买入 |
100,000 |
$0.59 |
$59.11K |
480,010 |
| 2024-06-17 |
Smith Robert Paul Jr |
Chief Commercial Officer |
知情买入 |
25,000 |
$0.60 |
$15.05K |
25,000 |
| 2024-06-06 |
Cox Russell J. |
Director |
限制性股票授予 (RSU) |
115,000 |
$0.60 |
$69K |
115,000 |
| 2024-06-06 |
Daniel Thomas O |
Director |
限制性股票授予 (RSU) |
115,000 |
$0.60 |
$69K |
115,000 |
| 2024-06-06 |
Quisel John D |
Director |
限制性股票授予 (RSU) |
115,000 |
$0.60 |
$69K |
115,000 |
| 2024-06-06 |
Milligan Sandra |
Director |
限制性股票授予 (RSU) |
115,000 |
$0.60 |
$69K |
115,000 |
| 2024-03-27 |
Hasnain Faheem |
President & CEO |
知情卖出 |
23,172 |
$1.16 |
$26.77K |
120,293 |
| 2024-03-27 |
Christian Waage |
EVP, Tech Ops and Admin |
知情卖出 |
6,430 |
$1.16 |
$7.43K |
585,934 |
| 2024-03-27 |
Giraudo Bryan |
COO/cfo |
知情卖出 |
6,430 |
$1.16 |
$7.43K |
92,737 |
| 2024-03-18 |
Peterson Caryn |
EVP, Regulatory Affairs |
知情卖出 |
4,018 |
$1.33 |
$5.34K |
49,833 |
| 2024-03-18 |
Aranda Richard |
Chief Medical Officer |
知情卖出 |
4,018 |
$1.33 |
$5.34K |
198,799 |
| 2024-03-11 |
Drynan Skye |
Director |
未知 |
- |
- |
- |
- |
| 2024-03-11 |
Drynan Skye |
Director |
限制性股票授予 (RSU) |
230,000 |
$1.34 |
$308.2K |
230,000 |
| 2024-03-11 |
Nathan Steven D |
Director |
未知 |
- |
- |
- |
- |
| 2024-03-11 |
Nathan Steven D |
Director |
限制性股票授予 (RSU) |
230,000 |
$1.34 |
$308.2K |
230,000 |
| 2024-01-02 |
Hasnain Faheem |
President & CEO |
限制性股票授予 (RSU) |
1,312,500 |
$0.97 |
$1.27M |
1,312,500 |
| 2024-01-02 |
Christian Waage |
EVP, Tech Ops and Admin |
限制性股票授予 (RSU) |
375,000 |
$0.97 |
$363.75K |
375,000 |
| 2024-01-02 |
Giraudo Bryan |
COO/cfo |
限制性股票授予 (RSU) |
543,750 |
$0.97 |
$527.44K |
543,750 |
| 2024-01-02 |
Peterson Caryn |
EVP, Regulatory Affairs |
限制性股票授予 (RSU) |
375,000 |
$0.97 |
$363.75K |
375,000 |
| 2024-01-02 |
Aranda Richard |
Chief Medical Officer |
限制性股票授予 (RSU) |
487,500 |
$0.97 |
$472.88K |
487,500 |
| 2023-12-04 |
Smith Robert Paul Jr |
Officer |
未知 |
- |
- |
- |
- |
| 2023-12-04 |
Smith Robert Paul Jr |
Chief Commercial Officer |
限制性股票授予 (RSU) |
1,500,000 |
$0.97 |
$1.45M |
1,500,000 |
| 2023-11-28 |
Quisel John D |
Director |
未知 |
- |
- |
- |
- |
| 2023-11-28 |
Quisel John D |
Director |
限制性股票授予 (RSU) |
230,000 |
$0.69 |
$158.93K |
230,000 |
| 2023-11-20 |
Hasnain Faheem |
President & CEO |
限制性股票授予 (RSU) |
437,500 |
$0.84 |
$366.63K |
437,500 |
| 2023-11-20 |
Christian Waage |
EVP, Tech Ops and Admin |
限制性股票授予 (RSU) |
125,000 |
$0.84 |
$104.75K |
125,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
